 |
Diagnostic Expertise NCGS Laboratories, Inc. (NCGS), founded in 1984, is a full service Contract Research Organization (CRO) focused upon study management, data management, quality assurance and regulatory compliance. Our corporate experience encompasses clinical product development of a diverse group of pharmaceutical, biological, device, botanical and diagnostic products. Our current in-house expertise covers the following therapeutics areas. |
| Elisa | |||||
| Product | Submission | Disease/Condition | #Patients/Samples | Intl | Dom |
| Ortho HCV 3.0 | PLA | Hepatitis | 4,500 samples total | X | X |
| Centocor Syph-G |
510(k) | Syphilis positives | 18,000 samples, 12,000 donors/patients | X | |
| Ortho HTLV I/II | PLA | HTLV screening | >6,000 donors/patients | X | |
| Ortho HBsAg, Sys III | PLA | Hep B screening & confirmatory | >13,000 donors/patients | X | |
| Ortho HIV I/II | PLA | HIV pos, HIV seroconverters | 4,500 samples total | X | X |
| Breast Ca Screen (preclinical) |
none | Precursor protien for Breast Ca. | 1,500 samples, 2 assays each | X | |
| Breast Ca Screen (preclinical) |
none | Baseline, Control & standards eval | 120 samples, 16 assays each | X | |